Recommended doses of formulations of hepatitis B vaccines licensed in the United States for infants, children, and adolescents younger than 18 years, by vaccine type and age group*
Adapted from: Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018; 67:1.
Additional data from: Vaxelis (Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, Haemophilus b conjugate [meningococcal protein conjugate] and hepatitis B [recombinant] vaccine. United States Prescribing Information. Revised December, 2018. US Food & Drug Administration. Available online:
www.fda.gov/BiologicsBloodVaccines/ucm629107.htm (Accessed on December 28, 2018).